Over 400 therapeutic studies have been published in rheumatology and clinicalimmunology and the number grows yearly. As such, it is quite difficult to keep track of the multitude of studies and the emerging trends. Further to this, a particular study can be referred to in a variety of ways, either a shortenedversion of the title or an acronym, adding to the confusion. Clinical Trials in Rheumatology provides a summary of all the studies in existence, for easy reference by those in the basic scientific and clinical communities who deal with immunosuppressive drugs. Every study is listed on one page each with authors, complete citation, name (and/or acronym), study aim(s), results and summary. An acronym finder is supplied at the end of the book. This book is a valuable reference tool for rheumatologists involved in clinical trials, as well as research scientists interested in immunosuppressant drugs. Puts all the basic information on clinical trials in this area (i.e. immunosuppressant drugs) intothe same place Provides all necessary information for delving deeper into anyof the trials presented by providing the journal citation Provides all of thevarious names by which a particular trial may be referred to at meetings or in other publications to mitigate confusion Appendix with all acronyms and other abbreviations of clinical trials for quick reference INDICE: Rheumatoid Arthritis:- Corticosteroids:- Atorvastatin:- Azathioprine:- Chloroquine/Hydroxychloroquine:- Ciclosporin:- Cyclophosphamide:- Gold:- Leflunomide:- Methotrexate:- Sulfasalazine:- Tacrolimus:- Combination Therapy:- Methotrexate and Hydroxychloroquine:- Methotrexate and Doxycycline:- Methotrexate and Sulfasalazine:- Methotrexate and Civlosporin:- Methotrexate and Hydroxychloroquine and Sulfasalazine:- Methotrexate and Leflunomide:- Methotrexateand Azathioprine:- Methotrexate and Gold:- Gold and Hydroxychloroquine:- Abatacept:- Adalimumab:- Anakinra:- Certolizumab pegol:- Etanercept:- Golimumab:- Infliximab:- Rituximab:- Tocilizumab:- Ankylosing Spondylitis:- Corticosteroids:- Cyclophosphamide:- Leflunomide:- Methotrexate:- Pamindronate:- Sulfasalazine :- Combination therapy:- Adalimumab:- Etanercept:- Golimumab:- Infliximab:-Psoriatic Arthritis;- Chloroquine/Hydroxychloroquine:- Ciclosporin:- Leflunomide:- Methotrexate:- Sulfasalazine:- Adalimumab:- Alefacept:- Etanercept:- Golimumab:- Infliximab:- Ustekinumab:- Systemic Lupus erythematosus:- Corticosteroids:- Azathioprine:- Chloroquine/Hydroxychloroquine:- Cyclophosphamide:- Leflunomide:- Methotrexate:- Mycophenolate mofetil:- Raloxifene:- Tacrolimus:- Combination:- Azathioprine + Ciclosporine:- Hydroxychloroquine and Mycophenolate mofetil:- Infliximab:- Rituximab:- Antiphospholipid Syndrome:- Aspirin vs. Heparin:- Heparin vs. Intravenous Immunoglobulins:- Prednisone + Aspirin:- Warfarin:- Progress. System Sclerosis:- Corticosteroids:- Ambrisentan:- Azathioprine:- Bosentan:- Chlorambucil:- Ciclosporin:- Colchicine:- Cyclophosphamide:- D-Penicillamine:- Methotrexate:- Mycophenolate mofetil:- 5-Fluorouracil:- Etanercept:- Infliximab: Rituximab: Plasma exchange:- Stem cell transplantation:- Raynaud’s phenomenon:- Bosentan:- Diltiazem:- Glyceryl Trinitrate:- Iloprost:- Nifedipine:- Sildenafil:- Dermato/Polymyositis:- Corticosteroids:- Cyclophosphamide:- Immunoglobulins:- Methotrexate:- Mycophenolate mofetil:- Anti-TNF:- Etanercept:- Rituximab:- Sjögren's syndrome:- Hydroxychloroquine:- Leflunomide:- Methotrexate:- Mycophenolate mofetil:- Pilocarpine:- Etanercept:- Infliximab:- Rituximab:- Takayasu arteritis:- Methotrexate:- Mycophenolate mofetil:- Anti-TNF:- Giant cell arteritis:- Corticosteroids:- Ciclosporin:- Methotrexate:- Etanercept:- Infliximab:- Polymyalgia rheumatica:- Corticosteroids:- Azathioprine:- Methotrexate:- Etanercept:- Infliximab:- ANCA-associated Vasculitis incl. trials combined with polyarteritis nodosa:- Azathioprine:- Co-Trimoxazole:- Cyclophosphamide:- Methotrexate:- Mycophenolate mofetil:- Anti-thymocyte globulin:- Etanercept:- Immunoglobulin:- Infliximab:- Plasma exchange:- Purpura Schoenlein Henoch:- Corticosteroids:- Azathioprine:- Ciclosporine:- Cyclophosphamide:- Morbus Behçet:- Corticosteroids:- Azathioprine:- Ciclosporine:- Colchicine:- Cyclophosphamide:- Dapsone:- Methotrexate:- Mycophenolate mofetil:- Tacrolimus:- Thalidomide:- Etanercept:- Infliximab:- Interferon alfa-2a:- Acronyms:- Abbreviations:-
- ISBN: 978-1-84996-383-1
- Editorial: Springer
- Encuadernacion: Cartoné
- Páginas: 672
- Fecha Publicación: 24/10/2010
- Nº Volúmenes: 1
- Idioma: Inglés